These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 4800573

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunologic safety of recombinant factor VIII. The rFactor VIII Clinical Trial Group.
    Abildgaard CF.
    Semin Hematol; 1991 Apr; 28(2 Suppl 1):44. PubMed ID: 1908127
    [No Abstract] [Full Text] [Related]

  • 3. Acquired circulating anticoagulants in hemophilia A.
    Strauss HS.
    N Engl J Med; 1969 Oct 16; 281(16):866-73. PubMed ID: 5812255
    [No Abstract] [Full Text] [Related]

  • 4. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J, Skulimowska J, Windyga J, Lopaciuk S, Kościelak J.
    Arch Immunol Ther Exp (Warsz); 2005 Oct 16; 53(4):352-6. PubMed ID: 16088320
    [Abstract] [Full Text] [Related]

  • 5. [Transfusion problems in immunocoagulopathies].
    Lechner K, Stych H.
    Bibl Haematol; 1971 Oct 16; 37():199-205. PubMed ID: 5138905
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunoreactive factor VIII in carriers of hemophilia A+ and A-.
    Lechner K.
    Thromb Diath Haemorrh; 1973 May 10; 29(2):240-6. PubMed ID: 4762253
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Detection of carriers of haemophilia.
    Ekert H, Helliger H, Muntz RH.
    Thromb Diath Haemorrh; 1973 Nov 10; 30(2):255-62. PubMed ID: 4589771
    [No Abstract] [Full Text] [Related]

  • 11. [Circulating anticoagulants against coagulation factors with special reference to anti-factor VIII:C].
    Aznar JA.
    Sangre (Barc); 1985 Nov 10; 30(4-C):813-8. PubMed ID: 3937252
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Poly-electrolyte fractionated porcine factor VIII in the treatment of hemophilia A].
    Ferencz T, Skopál J, Csáki C, Laczkó M, Schuler D, Borsi J.
    Orv Hetil; 1993 Dec 26; 134(52):2873-5. PubMed ID: 8272354
    [Abstract] [Full Text] [Related]

  • 16. [Circulating anticoagulants].
    Krulik M, Debray J, Vergoz D, Yvart J.
    Sem Hop; 1971 Jun 14; 47(28):1820-7. PubMed ID: 4327218
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Suppression of factor VIII antibody by combined factor VIII and cyclophosphamide.
    Nilsson IM, Hedner U, Holmberg L.
    Acta Med Scand; 1974 Jun 14; 195(1-2):64-72. PubMed ID: 4817094
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.